EUVIMEDEUVIMED entdecken
VergleichsstudieBeobachtungsstudieKohortenstudie

Remimazolam Besylate Versus Propofol for Procedural Sedation in Patients Undergoing Electrical Cardioversion: A Prospective, Noninferiority Cohort Study

Jacopo D'Andria Ursoleo, Alice Bottussi, Viviana Teresa Agosta, Gaia Barucco, Juan G Ripoll, Raphaël Cinotti, Patrick M Wieruszewski, Fabrizio Monaco

Journal of Cardiothoracic and Vascular Anesthesia · 2026-02 · 40 (2) · 546-553

DOI: 10.1053/j.jvca.2025.10.044 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Cardiothoracic and Vascular Anesthesia, 2026-02. Verfasst von Jacopo D'Andria Ursoleo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy. Hauptthemen laut MEDLINE: Propofol, Electric Countershock, Hypnotics and Sedatives, Benzodiazepines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Remimazolam besylate is a novel, short-acting benzodiazepine with a more favorable hemodynamic and respiratory profile than traditional anesthetics and may be suitable for procedural sedation. The objective of this study was to assess the safety, feasibility, and clinical advantages of remimazolam compared to propofol for procedural sedation during electrical cardioversion. DESIGN: A prospective observational study. SETTING: The Electrophysiology Department of a tertiary referral center university hospital. PARTICIPANTS: Sixty consecutive adult patients undergoing procedural sedation during electrical cardioversion for atrial fibrillation. INTERVENTION: Patients receiving remimazolam (n = 30) were compared to those receiving propofol (n = 30) for procedural sedation. MEASUREMENTS AND MAIN RESULTS: The primary outcome of time to loss of consciousness was evaluated in a prespecified noninferiority analysis. Other outcomes included adequacy of sedation, the time course of hemodynamics, time to recovery of consciousness, and adverse drug events. The achievement of satisfactory sedation was similar between the remimazolam (n = 29, 97%) and propofol (n = 30, 100%) groups. The mean difference in time to loss of consciousness between the groups was within the margin of noninferiority (0.41 minutes; 95% confidence interval, -0.38 to 1.20 minutes). In the linear mixed-effects model, remimazolam produced significantly more favorable blood pressure indexes but similar oxygen saturations compared to propofol over the course of the procedure. Three patients in the propofol group required rescue ventilation. CONCLUSIONS: Remimazolam was associated with similar sedation adequacy but more favorable hemodynamics over time compared to propofol when used for procedural sedation in adults undergoing electrical cardioversion for atrial arrhythmias.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PropofolElectric CountershockHypnotics and SedativesBenzodiazepinesProcedural SedationHumansMaleFemaleProspective StudiesMiddle AgedAgedCohort StudiesAtrial FibrillationAdult

Stichwörter der Autor:innen

atrial arrhythmiaelectrical cardioversionelectrophysiology laboratorypropofolremimazolamsedation

Substanzen

PropofolremimazolamHypnotics and SedativesBenzodiazepines

Autor:innen und Institutionen

  • Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Department of Anesthesiology, Mayo Clinic, Rochester, MN.
  • Department of Anaesthesia and Critical Care, CHU Nantes, Nantes Université, Nantes, France; UMR 1246 SPHERE "Methods in Patients-Centered Outcomes and HEalth Research," University of Nantes, University of Tours, Nantes,…
  • Department of Anesthesiology, Mayo Clinic, Rochester, MN; Department of Pharmacy, Mayo Clinic, Rochester, MN.
  • Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: fabrizio.monaco4@unibo.it.

Zitieren

APA

D'Andria Ursoleo, J., Bottussi, A., Agosta, V. T., Barucco, G., Ripoll, J. G., Cinotti, R., Wieruszewski, P. M., & Monaco, F. (2026). Remimazolam Besylate Versus Propofol for Procedural Sedation in Patients Undergoing Electrical Cardioversion: A Prospective, Noninferiority Cohort Study. Journal of Cardiothoracic and Vascular Anesthesia, 40(2), 546-553. https://doi.org/10.1053/j.jvca.2025.10.044

Vancouver

D'Andria Ursoleo J, Bottussi A, Agosta VT, Barucco G, Ripoll JG, Cinotti R, et al. Remimazolam Besylate Versus Propofol for Procedural Sedation in Patients Undergoing Electrical Cardioversion: A Prospective, Noninferiority Cohort Study. Journal of Cardiothoracic and Vascular Anesthesia. 2026;40(2):546-553. doi:10.1053/j.jvca.2025.10.044

BibTeX
@article{DAndriaUrsoleo2026,
  author = {D'Andria Ursoleo, Jacopo and Bottussi, Alice and Agosta, Viviana Teresa and Barucco, Gaia and Ripoll, Juan G and Cinotti, Raphaël and Wieruszewski, Patrick M and Monaco, Fabrizio},
  title = {Remimazolam Besylate Versus Propofol for Procedural Sedation in Patients Undergoing Electrical Cardioversion: A Prospective, Noninferiority Cohort Study},
  journal = {Journal of Cardiothoracic and Vascular Anesthesia},
  year = {2026},
  volume = {40},
  number = {2},
  pages = {546--553},
  doi = {10.1053/j.jvca.2025.10.044}
}
Kostenlos starten →